Rainbow Childrens Medicare Limited has informed the Exchange regarding a press release dated May 23, 2026, titled "Press Release on the Audited Financial Results (Standalone & Consolidated) for the quarter and financial year ended March 31, 2026.".
RAINBOW · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Rainbow Children's Medicare reported strong Q4 FY26 results with revenue of ₹4,599 Mn (up 24.3% YoY), EBITDA of ₹1,447 Mn (up 26.1% YoY), and PAT of ₹782 Mn (up 38.3% YoY). For the full year FY26, revenue stood at ₹17,031 Mn (up 12.4%) and PAT at ₹2,815 Mn (up 15.3%). The company expanded its network with new facilities in Bengaluru (HRBR ~60 beds and Mahadevapura IVF centre) and now operates 2,375 capacity beds with 1,806 operational beds. Key expansion projects in Coimbatore, Gurugram (Sector 44 and 56), and Pune are progressing as planned. The Board recommended a final dividend of ₹3.5 per equity share (35%). The company holds cash and equivalents of ₹5,942 Mn as of March 31, 2026.
Strong Q4 profit growth of 38% YoY and healthy full-year performance demonstrate operational execution capability. With the capacity expansion phase now largely complete, the focus shifts to occupancy ramp-up and operating leverage, which should support margins going forward. The healthy cash position and dividend signal financial stability.